Hillstream BioPharma Inc. (HILS)
NASDAQ: HILS
· Real-Time Price · USD
0.24
0.02 (7.00%)
At close: Sep 22, 2023, 9:59 PM
Hillstream BioPharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.82M | -2.34M | -2.69M | -1.77M | -2.13M | -1.64M | -2.94M | 2.45M | -853.44K | -1.56M | -2.25M |
Depreciation & Amortization | n/a | n/a | n/a | 1.57B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 157.96K | 158.03K | 345.43K | 202K | 240.76K | 338.55K | 19.38K | 6.74K | 4.43K | 554.02K | 674.08K |
Other Working Capital | 504.91K | 201.33K | 280.62K | 68.45K | 84.05K | -325.83K | -254.61K | -20K | 45.97K | -105.1K | 276.06K |
Other Non-Cash Items | 250K | n/a | n/a | -1.57B | n/a | n/a | 1.67M | -2.6M | 267.54K | 419.34K | 748.37K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 503.19K | 667.86K | -1.12M | 486.12K | 61.35K | -363.76K | -752.83K | 133.98K | 264.68K | 313.31K | 335.24K |
Operating Cash Flow | -908.97K | -1.51M | -3.46M | -1.06M | -1.83M | -1.66M | -2.01M | -7.67K | -316.78K | -269.42K | -492.37K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -7.82K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -306.01K | 1.85M | 523.36K | -22.46K | -62.15K | 24.39K | 13.12M | -33.06K | 332.6K | 276.19K | 323.02K |
Financial Cash Flow | -306.01K | 1.85M | 523.36K | -22.46K | -62.15K | 24.39K | 13.12M | -33.06K | 332.6K | 276.19K | 323.02K |
Net Cash Flow | -1.21M | 334.82K | -2.94M | -1.09M | -1.89M | -1.64M | 11.12M | -40.74K | 15.82K | 6.76K | -169.34K |
Free Cash Flow | -908.97K | -1.51M | -3.46M | -1.06M | -1.83M | -1.66M | -2.01M | -7.67K | -316.78K | -269.42K | -492.37K |